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Abstract 
Aims: To establish if aerobic exercise training is associated with beneficial effects on clinical outcomes and glycaemic 
profile in people with type II diabetes.
Methods: A systematic search was conducted to identify studies through a search of MEDLINE (1985 to Sept 1, 2016, 
Cochrane Controlled Trials Registry (1966 to Sept 1, 2016), CINAHL, SPORTDiscus and Science Citation Index. The 
search strategy included a mix of MeSH and free text terms for related key concepts. Searches were limited to pro-
spective randomized or controlled trials of aerobic exercise training in humans with type II diabetes, aged >18 years, 
lasting >2 weeks.
Results: Our analysis included 27 studies (38 intervention groups) totalling 1372 participants, 737 exercise and 
635 from control groups. The studies contain data from 39,435 patient-hours of exercise training. Our analyses 
showed improvements with exercise in glycosylated haemoglobin (HbA1C%) MD: −0.71%, 95% CI −1.11, −0.31; 
p value = 0.0005. There were significant moderator effects; for every additional week of exercise HbA1C% reduces 
between 0.009 and 0.04%, p = 0.002. For those exercising at vigorous intensity peak oxygen consumption (peak VO2) 
increased a further 0.64 and 5.98 ml/kg/min compared to those doing low or moderate intensity activity. Homeostatic 
model assessment of insulin resistance (HOMA-IR) was also improved with exercise MD: −1.02, 95% CI −1.77, −0.28; 
p value = 0.007; as was fasting serum glucose MD: −12.53 mmol/l, 95% CI −18.94, −6.23; p value <0.0001; and serum 
MD: −10.39 IU, 95% CI −17.25, −3.53; p value = 0.003.
Conclusions: Our analysis support existing guidelines that for those who can tolerate it, exercise at higher intensity 
may offer superior fitness benefits and longer program duration will optimize reductions in HbA1C%.
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Background
Meta-analyses have shown lifestyle (diet and exercise) 
interventions to be beneficial for managing type II diabe-
tes [1]. Furthermore it has been demonstrated that differ-
ent exercise training modalities produce different effects 
on glycaemic control in those with type II diabetes, with 
combined aerobic and resistance exercise reported to be 
most beneficial [2, 3]. The gold standard measurement of 
fitness peak oxygen consumption (peak VO2) may also be 
improved [4] as well as glycaemic control [5] in individu-
als with type II diabetes. In the general population, high 
intensity interval training has shown to be more effective 
in regulating glucose than continuous training at lower 
intensity [6]. Moreover high intensity exercise training 
has been shown to be superior to lower intensity exercise 
for improving peak VO2 in cardiac patients [7, 8].
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Higher-volume high intensity training (HIIT) with 
4  ×  4  min per session elicited greater improvements 
than 1 × 4 min of HIIT, or moderate intensity training, 
in insulin quality in metabolic syndrome (MetS) par-
ticipants without type 2 diabetes. Both home-based and 
hospital-based HIIT in cardiac rehabilitation induce 
promising long-term exercise adherence [9]. However, 
there are reasons why moderate intensity exercise train-
ing is preferred to high intensity, even though health 
benefits may be greater with the latter. These reasons are: 
the stimulus from exercise at any intensity is considered 
sufficient to exert clinical improvements; intuitively one 
may consider lower intensity exercise training mitigates 
the likelihood of exercise related medical events; low to 
moderate intensity exercise can be performed by most 
people [7].
The life of a red blood cell is approximately 4 months, 
but many exercise training studies are of shorter duration 
than this. Glycosylated haemoglobin (HbA1C%) is the 
blood marker that quantifies the 3-month average plasma 
glucose concentration. Intuitively an exercise program 
would take longer than 12 weeks to demonstrate an effect 
on glycosylated haemoglobin HbA1C%, however many 
studies are of 12 weeks or fewer duration. It is therefore, 
also of interest to examine the effect of exercise training 
duration on HbA1C% and other markers of glycaemic 
control.
We conducted a systematic analysis of all clinical ran-
domized, controlled, aerobic exercise training trials in 
people with type II diabetes and stratified the trials by 
exercise intensity according to recognized guidelines 
[10]. Our systematic review and meta-analysis work had 
three aims: First, we aimed to quantify the effect of aero-
bic exercise on change in markers of glycaemic control 
and peak VO2 compared to sedentary controls. Second, 
we aimed to establish if high/vigorous intensity interval 
training produces larger changes in markers of glycaemic 
control and peak VO2 compared to moderate/low inten-
sity training and sedentary controls. Third, we wished 
to establish if exercise training duration produces better 
glycaemic control and peak VO2.
Methods
Search strategy
Studies were identified through a MEDLINE search strat-
egy (1985 to Sept 1, 2016), Cochrane Controlled Trials 
Registry (1966 to Sept 1, 2016), CINAHL, SPORTDis-
cus and Science Citation Index. The search strategy 
included a mix of MeSH and free text terms for the key 
concepts related to exercise training, high intensity inter-
val exercise, peak VO2, type II diabetes, glycaemic con-
trol, insulin sensitivity and insulin resistance for clinical 
trials of exercise training in people with type II diabetes. 
Studies were included if patients exhibited a diagnosis 
of type II diabetes. Searches were limited to prospective 
randomized, controlled trials of aerobic exercise train-
ing in humans, aged >18 years, lasting 2 weeks or more, 
supervised and unsupervised program were included. 
No restrictions were placed on the year, or language, of 
publication. Reference lists of papers and latest editions 
of relevant journals which were not available online were 
scrutinised for new references. Full articles were read 
and assessed by three reviewers (NS, AG and EC) for rel-
evance and study eligibility. Disagreements on methodol-
ogy were resolved by discussion, a fourth reviewer (FG) 
adjudicated over any disputes. Study authors were con-
tacted and requested to provide further data if required.
Study selection
Included studies were randomized controlled trials of 
exercise training, of 6  weeks or longer, supervised or 
unsupervised, in people with type II diabetes. Although 
some outcomes such as HbA1C% are unlikely to change 
in less than 12 weeks, peak VO2 etc. will change in this 
time period [11, 12]. Studies of type I diabetes were 
excluded to maintain a homogeneous study population 
and the type I patients may have made up disproportion-
ately fewer total patients. Resistance training studies were 
excluded as they tend not to use or measure peak VO2 as 
an outcome measure and there are too few isolated resist-
ance studies to warrant an analysis. As a result resistance 
study data were not included in our analysis. All pub-
lished studies included in this systematic review were 
comparisons between exercise study groups and control. 
Reviewers categorized the studies into four groups based 
on exercise intensity. The categorization were based on 
the position stand by Exercise and Sport Science Aus-
tralia [10]. The measures used to classify exercise inten-
sity were percentage of Heart Rate Maximum (%HRmax), 
Heart Rate Reserve (%HRR), Peak Oxygen Uptake (%VO2 
Peak) and Borg scale score [10].
In addition to the records identified through database 
searching, reference lists of identified records were scru-
tinized. Only the principal study with the greatest num-
ber of subjects were included where multiple publications 
existed from the same dataset. After initial screening 
over-lapping, duplicates, duplicate data and irrelevant 
articles such as editorials and discussion papers that 
did not match the inclusion criteria were removed. We 
excluded studies where the control group received addi-
tional intervention, non-relevant studies; studies using 
non-aerobic exercise training and those reporting only 
acute exercise testing responses. We excluded studies 
from specific analyses if incomplete data was reported 
and the authors did not respond to our requests to pro-
vide missing data.
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Outcomes measures
We recorded the following data; percentage change 
in HbA1C%, Homeostatic model assessment of insu-
lin resistance (HOMA-IR), lean body mass, BMI, body 
composition, peak VO2 (only where this was measured 
directly during peak exercise), fasting glucose and insulin 
at baseline and post exercise. We also recorded exercise 
training frequency, intensity, duration per-session, length 
of exercise program.
Data synthesis
From extracted data we calculated patient-hours of exer-
cise training, percentage change in outcome measures.
Assessment of study quality
We assessed study quality with regard to: eligibility cri-
teria specified, random allocation of participants, alloca-
tion concealed, similarity groups at baseline, assessors 
blinded, outcome measures assessed in 85% of partici-
pants and intention to treat analysis. The study qual-
ity was assessed according to the validated Tool for the 
assEssment of Study qualiTy and reporting in EXercise 
(TESTEX). TESTEX is a study quality and reporting 
assessment tool, designed specifically for use in exercise 
training studies. which has a maximum score of 15 [13]. 
The main point of difference in TESTEX is that there 
are accommodations for: Activity monitoring in control 
groups to measure crossover to exercise by sedentary 
control patients; Assessment of the existence and method 
of activity monitoring in both exercise intervention and 
sedentary controls; Assessment of whether the rela-
tive exercise intensity remained constant and therefore 
potentially avoided de-training as participants initially 
adapt to new exercise programs; Assessment of whether 
periodic evidence-based adjustment of exercise inten-
sity is reported exercise volume and exercise expendi-
ture Information on all exercise characteristics (intensity, 
duration, frequency and mode) is provided to calculate 
exercise volume and exercise energy expenditure.
This tool is a 15-point scale (5 points for study qual-
ity and 10 points for reporting) and addresses previously 
unmentioned quality assessment criteria specific to exer-
cise training studies. Two reviewers NS and FG con-
ducted the risk of bias assessment, PG was consulted of 
discrepancies occurred. No minimum TESTEX score was 
required for a study to be included in the analysis.
Statistical analyses
A mixed-effects meta-analysis model was used to esti-
mate the effect of exercise versus control for the out-
comes of interest while controlling for the repeated 
measures arising in multi-arm studies and over time 
for the same study. The metafor [14] package within R 
statistical software was used to conduct the meta-analy-
ses and create forest plots [15].
Continuous outcomes were reported as mean differ-
ence between exercise and control and/or relative change 
from baseline scores depending on the data extracted 
with 95% confidence intervals (CI).
We used a 5% level of significance to report differ-
ences between intensity and control in each of the out-
come measures. Egger bias tests were employed if at least 
10 studies were included for a given outcome [16]. Het-
erogeneity is presented as the estimated between studies 
variability, τ2 with 95% CI. A multivariate generalization 
of the I2 statistic is also provided.
Meta‑regression
Meta-regression was performed to determine whether 
exercise volume variables and possible predictors (exer-
cise intensity, program duration and patient-hours of 
exercise, publication date) of change in outcome meas-
ures mediated the differences between treatment and 
control. This was not undertaken if there were fewer than 
10 studies in a given analysis.
Results
Our initial search identified 59 manuscripts, hand 
searching of reference lists of included studies and key 
articles such as related reviews and the latest editions of 
relevant journals yielded a further 3 manuscripts. Out of 
these 62 studies, 6 were excluded at first inspection as 
duplicates, 17 were not controlled trials of exercise ther-
apy, 2 were excluded as they had participants <18 years, 
2 were excluded as they were not randomized trials, 6 
used unmatched interventions or comparator groups 
and 2 were counselling interventions encouraging exer-
cise participation, leaving 27 included studies for analysis 
(PRISMA Statement—Fig. 1).
The 27 studies (38 intervention groups) comprised 1372 
participants, 737 exercise and 635 from control groups 
[3, 17–42]. The studies contain data from 39,435 patient-
hours of exercise training. Studies ranged in duration 
form 4–52 weeks (average 17.8 weeks, median 13 weeks), 
and 2–5 weekly exercise sessions (median =  3), session 
duration ranged from 15 to 75 min (median = 50), mean 
weekly exercise time was 40–300  min (mean 157  min, 
median = 150 min). All were studies of aerobic exercise, 
24 intervention groups used vigorous intensity, 1 used 
low intensity, 1 was unclassified with regards to intensity 
and 12 used moderate intensity (see Table 1).
Meta‑analyses
HbA1C%
Twenty intervention groups provided data on HbA1C%. 
Results indicated that there was a significant reduction 
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in the exercise versus control groups HbA1C%, MD: 
−0.69%, 95% CI −1.09, −0.30; p value = 0.0005 (Fig. 2). 
Cochran’s Q-test indicates significant heterogeneity 
between studies (Q  =  440, df  =  28, p value  <0.0001; 
between studies variability: τ2  =  0.61, 95% CI 0.31, 
1.36; I2 =  89.8%). An Egger bias test indicated no evi-
dence of funnel plot asymmetry (p value  =  0.710). 
There was one significant moderator effect; exercise 
program duration (weeks). For every additional week of 
follow-up HbA1C% reduces between 0.009 and 0.043%, 
p = 0.002.
HOMA‑IR
Seven studies provided data on HOMA-IR. Results 
indicated a significant improvement in HOMA-IR in 
exercise participants versus control MD: −1.02, 95% CI 
−1.77, −0.28; p value = 0.007 (Fig. 3). Cochran’s Q-test 
indicated significant heterogeneity between studies 
(Q = 113, df = 11, p value <0.0001; between studies vari-
ability: τ2 =  0.72, 95% CI 0.22, 3.54; I2 =  83.7%). There 
were too few studies to allow investigation of moderator 
effects or to perform an Egger bias test.
Fasting insulin
Eight intervention groups provided data on insu-
lin. Results suggested a significant reduction in serum 
insulin in the exercise participants versus control MD: 
−10.39  IU, 95% CI −17.25, −3.53; p value =  0.003 (see 
Additional file  1). Cochran’s Q-test indicates signifi-
cant heterogeneity between studies (Q  =  304, df  =  10, 
p value <0.0001; between studies variability: τ2 = 136.8, 
95% CI 41.0, 646.0; I2 = 94.5%). There were too few stud-
ies to allow investigation of moderator effects or to per-
form an Egger bias test.
Fig. 1 Consort statement
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Fasting blood glucose
Eighteen studies provide data on fasting blood glucose. 
Results indicated that there was a significant reduc-
tion in serum glucose in exercise participants versus 
control MD: −12.53  g.DL−1, 95% CI −18.94, −6.23; p 
value  <0.0001 (see Additional file  1). Cochran’s Q-test 
indicates significant heterogeneity between studies 
(Q = 522, df = 23, p value <0.0001; between studies vari-
ability: τ2 =  136.1, 95% CI 56.8, 361.9; I2 =  94.2%). An 
Egger bias test indicated no evidence of funnel plot asym-
metry (p value = 0.862). There were no significant mod-
erator effects.
Body mass index
Nineteen intervention groups were analysed for 
body mass index (BMI) which suggested significantly 
reduced BMI in exercise versus control participants 
MD—1.56 kg m−2, 95% CI −2.41, −0.71; p value = 0.0003 
Table 1 Included study characteristics
Study Date Country No. exercise No. control Weeks Exercise intensity
Agurs-Collins et al. 12 weeks 1997 USA 32 32 12 Moderate
Agurs-Collins et al. 24 weeks 1997 USA 32 32 24 Moderate
Balducci et al. 13 weeks 2010 Italy 20 20 13 Vigorous
Balducci et al. 26 weeks 2010 Italy 20 20 26 Vigorous
Balducci et al. 39 weeks 2010 Italy 20 20 39 Vigorous
Balducci et al. 52 weeks 2010 Italy 20 20 52 Vigorous
Belli et al. 2011 Brazil 9 10 12 Moderate
Boudou et al. 2000 France 8 8 9 Vigorous
Choi et al. 2012 Korea 38 37 12 Moderate
Church et al. 2010 USA 72 41 39 Vigorous
Cuff et al. 2003 Canada 9 9 16 Vigorous
de Oliveira 2012 Brazil 11 12 12 Moderate
da Silva et al. low 2011 Brazil 10 11 6 Low
da Silva et al. vigorous 2012 Brazil 10 11 6 Vigorous
Jorge 2011 Brazil 12 12 12 Moderate
Kadoglou 2007 Greece 30 30 26 Vigorous
Karstoft et al. continous 2013 Denmark 12 8 17 Moderate
Karstoft et al. interval 2013 Denmark 12 8 17 Vigorous
Lambers 2008 Belgium 19 16 12 Vigorous
Madden 2013 Canada 10 10 12 Vigorous
Mitranun et al. continuous 2014 Thailand 14 15 12 Moderate
Mitranun et al. interval 2014 Thailand 14 15 12 Vigorous
Moghadasi 2013 Iran 8 8 12 Moderate
Morton 2010 UK 15 12 7 Vigorous
Motahari-Tabari et al. 4 weeks 2014 Iran 27 26 4 Moderate
Motahari-Tabari et al. 8 weeks 2014 Iran 27 26 8 Moderate
O’Donovan et al. moderate 2005 UK 10 13 24 Moderate
O’Donovan et al. vigorous 2005 UK 13 13 24 Vigorous
Raz et al. 1994 Israel 19 19 12 Vigorous
Rönnemaa 1986 Finland 15 15 17 Vigorous
Shenoy 2010 India 20 20 8 Vigorous
Short 2003 USA 65 37 16 Vigorous
Sigal 13 weeks 2007 Canada 60 63 13 Vigorous
Sigal 26 weeks 2007 Canada 60 63 26 Vigorous
Sridhar 2010 India 30 22 52 Unclear
Sung 13 weeks 2012 Korea 22 18 13 Vigorous
Sung 26 weeks 2012 Korea 22 18 26 Vigorous
Yavari 2012 Iran 35 30 16 Vigorous
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(see Additional file  1). Cochran’s Q-test showed no evi-
dence of heterogeneity between studies (Q = 27, df = 26, 
p value = 0.39; between studies variability: τ2 = 0.78. 95% 
CI 0.00; 4.71; I2 = 36.4%). An Egger bias test showed no 
evidence of funnel plot asymmetry (p value  =  0.884). 
There were no significant moderator effects.
Lean body mass
Six studies were included in the analysis. Results for 
lean body mass indicated no difference between exercise 
and control groups MD: −0.44  kg 95% CI −1.19, 0.31; 
p value = 0.246 (see Additional file 1). Cochran’s Q-test 
indicates no evidence of heterogeneity between stud-
ies (Q  =  1.28, df  =  7, p value  =  0.991; between study 
variability: τ2  =  0.00, 95% CI 0.00, 8.00; I2  =  0.00%). 
There were too few studies to test for moderator effects 
or funnel plot asymmetry.
Fat mass
Six intervention groups provided data on fat mass. 
Results indicate that there was no difference between 
exercise and control MD: −0.47 kg 95% CI −1.54, 0.61; 
p value = 0.396 (see Additional file 1). Cochran’s Q-test 
indicates no evidence of heterogeneity between studies 
(Q = 5, df = 7, p value = 0.703; between studies variabil-
ity: τ2 = 0.00, 95% CI 0.00, 10.0; I2 = 0.00%). There were 
too few studies to be able to test for moderator effects or 
funnel plot asymmetry.
Fig. 2 Change in HbA1C% exercise vs control
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Cardiorespiratory fitness (peak VO2)
Twelve intervention groups provided data on peak VO2 
(ml/kg/min). Results show a significant improvement in 
exercise participants versus control MD: 3.40 ml/kg/min, 
95% CI 1.65, 5.15; p value = 0.0001 (see Fig. 4). Cochran’s 
Q-test indicates significant heterogeneity between stud-
ies (Q  =  79, df  =  13, p value  <0.0001; between stud-
ies variability: τ2 = 6.61, 95% CI 1.72, 23.2; I2 = 85.3%). 
There was no evidence of funnel plot asymmetry (Egger 
bias test p value = 0.815). There was a significant mod-
erator effect; participants  undertaking vigorous exercise 
had significantly higher peak VO2 max (between 0.64 
and 5.98 ml/kg/min more) than participants undertaking 
low/moderate exercise (p = 0.015).
Study quality
Median TESTEX score was 7. Several aspects of study 
design were conducted poorly on more than 50% (13) 
studies; the method of randomization was only clearly 
stated in 9/27 studies; group allocation was only con-
cealed from assessors in 5 studies; assessor blinding was 
only employed in 4 studies; intention to treat analysis was 
only done in 3 studies; physical activity monitoring of 
controls was only performed in 1 study; exercise inten-
sity was periodically reviewed in only 5 studies (see Addi-
tional file 1: Table S2).
Discussion
Our work is the first to conduct a data pooling analysis 
of the effects of exercise training and associated modera-
tor variables on clinical markers of diabetes control. Our 
analyses showed improvements in HbA1C%, HOMA-IR, 
serum insulin and glucose and peak VO2. There remains 
insufficient published data to conduct moderator effects 
in but a handful of the reported outcome measures, how-
ever it is likely that exercise program duration and inten-
sity have a moderating role.
HbA1C% showed a significant improvement with exer-
cise training. As the median duration of included studies 
was 13 weeks, which is a similar duration to the life of a 
red blood cell, it is therefore encouraging that changes in 
HbA1C% via exercise training are possible in such a short 
timeframe. We conducted sub-analyses and found that 
for every extra week of exercise training one can expect 
a reduction in HbA1C% compared to control. While this 
is effect is small it reinforces the importance of sustained 
lifestyle changes to effect health improvements.
Our work showed that exercise training improved 
HOMA-IR. HOMA-IR values above or equal to 2.0 or 2.5 
show enhanced diagnostic value in distinguishing those 
with metabolic disease from healthy individuals [43]. Our 
work showed exercise training elicited a mean difference 
improvement in HOMA-IR of greater than 1.0 indicat-
ing a large effect size. One would expect that a reduction 
Fig. 3 Change in HOMA-IR exercise vs control
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in HOMA-IR of 1.0 would have a profound effect on the 
metabolic profile of an individual. We were unable to 
establish if any of the moderator variables influenced the 
magnitude of change in HOMA-IR.
We found BMI to be favourably altered with exercise. 
While point estimates showed a reduction in lean body 
mass and fat body mass the reductions were not signifi-
cant in exercising participants versus sedentary controls 
though this may be due to the small number of studies 
combined. No moderator variables were found to influ-
ence the magnitude of these changes. Our findings are 
expected in participants who exhibit improvements in 
HbA1C% and HOMA-IR.
The change in Peak VO2 was the order of 1 MET and 
this moderate effect is to be expected from a known 
chronic disease group who notoriously exhibit seden-
tary behaviour. Our meta-regression analysis of exercise 
intensity found a more pronounced increase in peak 
VO2 with vigorous versus low-moderate intensity train-
ing. Previous work has shown that intensity is the pri-
mary stimulus for improved peak VO2 in people with 
cardiac disease [8, 44]. It is remarkable that the exercise 
recommendations for diabetes were one of the first to 
offer a sliding exercise prescription scale, based upon the 
manipulation of intensity and weekly duration in order to 
keep work volume relatively constant [45]. These guide-
lines suggest 270 weekly minutes of moderate intensity 
exercise but only 90  min of vigorous intensity activity. 
Our work supports the existence of a two-tiered exer-
cise prescription as exercise at vigorous intensity is likely 
to produce a small to moderate reduction, beyond that 
observed with moderate intensity exercise, in HbA1C%.
We did not observe any moderating effects of exercise 
program duration on peak VO2. One may expect intui-
tively that increasing exercise program duration would 
produce greater improvements in peak VO2. It is there-
fore perhaps surprising that studies comparing shorter 
and longer exercise program durations have produced 
non-uniform effects on peak VO2 [7, 8, 46]. The likely 
explanation for this phenomenon is that it may be more 
difficult to get patients to continue to adhere to an exer-
cise program in the longer term.
There is a broad consensus that physical activity rep-
resents a natural strong anti-inflammatory and metab-
olism-improving strategy with minor side effects, this is 
likely to be true in people with T2DM undertaking aero-
bic training, even in water can to reduce glucose levels in 
this patient group [47, 48]. Moreover, there is a quanti-
tative relationship between HbA1c levels and plaque tex-
ture in ultrasonic images of atherosclerotic patients [49], 
Fig. 4 Change in peak VO2 exercise vs control
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and in those without identified carotid plaques, beneficial 
effect of exercise training on carotid IMT progression has 
been demonstrated [50]. On the other hand, these favora-
ble effects have not been always seen [51].
Study limitations
Most of the meta-analyses exhibited heterogeneity that 
was not substantially reduced through a systematic 
attempt to identify reasons for heterogeneity by grouping 
studies according to similarities in outcome reporting or 
meta-regression.
The exercise training programs varied greatly between 
studies with respect to exercise intensity, duration, fre-
quency and modality. We accounted for duration via the 
statistical model used and the other variables via meta-
regression however, for the most part the meta-regressions 
were not significant. Despite the heterogeneous study 
designs, the Egger bias tests suggested no evidence of funnel 
plot asymmetry suggesting minimal risk of publication bias.
Few included studies accurately quantified the volume 
of incidental and structured physical activity, this has 
been performed previously in people with T1DM [52].
Measures of lean, and fat, body mass would have shed 
more light onto the role that body composition plays in 
improving glycaemic control through exercise. We would 
like to have conducted more moderator variable analyses 
but limited extracted data precluded this. We were only 
able to consider program duration, and high/vigorous 
versus low/moderate exercise intensity sub-analyses.
Finally, whether comorbidity (i.e. concomitant car-
diac disease, chronic obstructive pulmonary disease, 
etc.) impact on exercise-induced improvement of peak 
VO2 and glycaemic profile according to exercise training 
modalities remains to be elucidated.
Conclusions
Our pooled analysis of aerobic exercise studies showed a 
significant improvement in both HbA1C% and peak VO2. 
Moreover our data support existing guidelines that for 
those who can tolerate it, exercise at higher intensity may 
offer superior benefits. Longer exercise program duration 
will also optimize reductions in HbA1C%.
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